The first was a heterozygous pathogenic variant in BBS9 (c.1120C > T; p. Arg374∗), which results in premature protein termination and has been previously reported in individuals with Bardet-Biedl Syndrome [16]. Here, BBS9 is linked to Bardet-Biedl syndrome.